Search Results - "KINKEL, R. P"

Refine Results
  1. 1

    In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI by MAINERO, C, BENNER, T, RADDING, A, VAN DER KOUWE, A, JENSEN, R, ROSEN, B. R, KINKEL, R. P

    Published in Neurology (22-09-2009)
    “…We used ultra-high field MRI to visualize cortical lesion types described by neuropathology in 16 patients with multiple sclerosis (MS) compared with 8…”
    Get full text
    Journal Article
  2. 2

    Axonal loss in normal-appearing white matter in a patient with acute MS by BJARTMAR, C, KINKEL, R. P, KIDD, G, RUDICK, R. A, TRAPP, B. D

    Published in Neurology (09-10-2001)
    “…Brain imaging studies detect abnormalities in normal-appearing white matter in patients with MS. To investigate the histopathologic basis for these changes in…”
    Get full text
    Journal Article
  3. 3

    Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria by O’Connor, P, Kinkel, RP, Kremenchutzky, M

    Published in Multiple sclerosis (01-06-2009)
    “…Approximately 85% of multiple sclerosis (MS) cases begin as clinically isolated syndromes (CIS). Results from the Controlled High-Risk Subjects Avonex®…”
    Get full text
    Journal Article
  4. 4

    Ten-year follow-up of the ‘minimal MRI lesion’ subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial by Simon, JH, Kinkel, RP, Kollman, C, O’Connor, P, Fisher, E, You, X, Hyde, R

    Published in Multiple sclerosis (01-04-2015)
    “…Background: Patients with clinically isolated syndrome (CIS) and characteristic magnetic resonance imaging (MRI) lesions are at high risk for multiple…”
    Get full text
    Journal Article
  5. 5

    Fatigue in multiple sclerosis : Cross-sectional correlation with brain MRI findings in 71 patients by BAKSHI, R, MILETICH, R. S, HENSCHEL, K, SHAIKH, Z. A, JANARDHAR, V, WASAY, M, STENGEL, L. M, EKES, R, KINKEL, P. R

    Published in Neurology (22-09-1999)
    “…Fatigue is an unexplained but common and disabling symptom in MS. We assessed fatigue in 71 patients with MS and identified MS-fatigue (MSF) and MS-nonfatigue…”
    Get full text
    Journal Article
  6. 6

    A Wallerian degeneration pattern in patients at risk for MS by SIMON, J. H, KINKEL, R. P, JACOBS, L, BUB, L, SIMONIAN, N

    Published in Neurology (14-03-2000)
    “…Demyelination alone may not explain the progressive disability that frequently develops in MS. An alternative explanation for irreversible disability assumes a…”
    Get full text
    Journal Article
  7. 7

    Fatigue in multiple sclerosis and its relationship to depression and neurologic disability by Bakshi, R., Shaikh, Z.A., Miletich, R.S., Czarnecki, D., Dmochowski, J., Henschel, K., Janardhan, V., Dubey, N., Kinkel, P.R.

    Published in Multiple sclerosis (01-03-2000)
    “…We studied multiple sclerosis fatigue (MSF) and its relationship to depression and disability. Seventy-one patients [50 relapsing-remitting, 21 secondary…”
    Get full text
    Journal Article
  8. 8

    Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation by GORMAN, M. P, GOLOMB, M. R, WALSH, L. E, HOBSON, G. M, GARBERN, J. Y, KINKEL, R. P, DARRAS, B. T, URION, D. K, EKSIOGLU, Y. Z

    Published in Neurology (17-04-2007)
    “…A 10-year-old boy developed corticosteroid-responsive relapsing neurologic signs, including nystagmus and ataxia. MRI revealed multifocal T2 white matter…”
    Get full text
    Journal Article
  9. 9

    Working-age persons with multiple sclerosis and access to disease-modifying medications by Iezzoni, L.I., Ngo, L.H., Kinkel, R.P.

    Published in Multiple sclerosis (01-01-2008)
    “…US residents can face serious financial barriers to obtaining prescription medications, including disease-modifying medications for multiple sclerosis (MS). We…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Brain MRI lesions and atrophy are related to depression in multiple sclerosis by Bakshi, Rohit, Czarnecki, Donna, Shaikh, Zubair A, Priore, Roger L, Janardhan, Vallabh, Kaliszky, Zoltan, Kinkel, Peter R

    Published in Neuroreport (27-04-2000)
    “…It is unclear whether brain MRI lesions are associated with depression in multiple sclerosis (MS). Neurological dysfunction in depressed (n = 19) and…”
    Get full text
    Journal Article
  12. 12

    A phase II study of IV methylprednisolone in secondary-progressive multiple sclerosis by GOODKIN, D. E, KINKEL, R. P, WEINSTOCK-GUTTMAN, B, VANDERBRUG MEDENDORP, S, SECIC, M, GOGOL, D, PERRYMAN, J. E, UCCELLI, M. M, NEILLEY, L

    Published in Neurology (01-07-1998)
    “…To compare the tolerability and efficacy of two doses of i.v. methylprednisolone in patients with secondary-progressive MS. I.v. methylprednisolone…”
    Get full text
    Journal Article
  13. 13

    Management of Multiple Sclerosis by Rudick, Richard A, Cohen, Jeffrey A, Weinstock-Guttman, Bianca, Kinkel, Revere P, Ransohoff, Richard M

    Published in The New England journal of medicine (27-11-1997)
    “…Multiple sclerosis is a common disease of the central nervous system affecting approximately 1 million young adults, mostly women, worldwide. 1 It is…”
    Get full text
    Journal Article
  14. 14

    Thrombotic thrombocytopenic purpura : Brain CT and MRI findings in 12 patients by BAKSHI, R, SHAIKH, Z. A, BATES, V. E, KINKEL, P. R

    Published in Neurology (12-04-1999)
    “…Clinical-neuroimaging analysis of 12 thrombotic thrombocytopenic purpura (TTP) patients revealed a variety of brain lesions. These included reversible cerebral…”
    Get full text
    Journal Article
  15. 15

    Diversity and plasticity of self recognition during the development of multiple sclerosis by Tuohy, V K, Yu, M, Weinstock-Guttman, B, Kinkel, R P

    Published in The Journal of clinical investigation (01-04-1997)
    “…Recent studies using murine animal model systems indicate that clinical progression of autoimmune disease may be due to the sequential accumulation of…”
    Get full text
    Journal Article
  16. 16

    In vivo evidence of disseminated subpial T2 signal changes in multiple sclerosis at 7 T: a surface-based analysis by Cohen-Adad, J, Benner, T, Greve, D, Kinkel, R P, Radding, A, Fischl, B, Rosen, B R, Mainero, C

    Published in NeuroImage (Orlando, Fla.) (01-07-2011)
    “…Cortical subpial demyelination is frequent in multiple sclerosis (MS) and is closely associated with disease progression and poor neurological outcome…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Occipital Lobe Seizures as the Major Clinical Manifestation of Reversible Posterior Leukoencephalopathy Syndrome: Magnetic Resonance Imaging Findings by Bakshi, Rohit, Bates, Vernice E., Mechtler, Laszlo L., Kinkel, Peter R., Kinkel, William R.

    Published in Epilepsia (Copenhagen) (01-03-1998)
    “…Purpose: Reversible posterior leukoencephalopathy syndrome (RPLS) is an increasingly recognized brain disorder most commonly associated with malignant…”
    Get full text
    Journal Article
  19. 19

    Fluid-Attenuated Inversion-Recovery MR Imaging in Acute and Subacute Cerebral Intraventricular Hemorrhage by Bakshi, Rohit, Kamran, Sadaat, Kinkel, Peter R, Bates, Vernice E, Mechtler, Laszlo L, Janardhan, Vallabh, Belani, Shaleen L, Kinkel, William R

    Published in American journal of neuroradiology : AJNR (01-04-1999)
    “…Fluid-attenuated inversion-recovery (FLAIR) MR imaging may show subarachnoid hemorrhage (SAH) with high sensitivity. We hypothesized that the FLAIR technique…”
    Get full text
    Journal Article
  20. 20

    Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis by Munschauer, Frederick E., Kinkel, Revere Philip

    Published in Clinical therapeutics (01-09-1997)
    “…In separate clinical trials, two preparations of recombinant interferon (IFN)-beta, IFN beta-1a and IFN beta-1b, reduced exacerbation rates in…”
    Get full text
    Journal Article